Last updated: October 17, 2022
Sponsor: Medical University of Vienna
Overall Status: Active - Recruiting
Phase
4
Condition
N/ATreatment
N/AClinical Study ID
NCT05492968
RACE_01
Ages 45-90 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- ≥ 45 years old
- Scheduled for moderate- to high-risk major open abdominal surgery expected to last atleast two hours
- ASA physical status ≥ 2
- At least one of the following risk factors:
- Age ≥75years
- History of peripheral arterial disease
- History of coronary artery disease
- History of stroke or transient ischemic attack/Stroke
- History of chronic kidney disease
- Diabetes requiring medical treatment
- Current smoking or history of 15 pack-years
- History of heart failure
- Preoperative high-sensitivity Troponin T ≥14ng.L-1
- Preoperative NT-proBNP ≥200 pg.mL-1
Exclusion
Exclusion Criteria:
- Scheduled for pheochromocytoma surgery
- Scheduled for liver and kidney transplantation
- Requiring preoperative intravenous vasopressor medications
- Contraindications to epinephrine, norepinephrine or phenylephrine per clinicaljudgement
- Permanent atrial fibrillation
- Preoperative heart rate >110 bpm
Study Design
Total Participants: 225
Study Start date:
September 01, 2022
Estimated Completion Date:
August 31, 2024
Study Description
Connect with a study center
Medical University of Vienna
Vienna, 1090
AustriaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.